Menu

Department
  • Psychiatry
  • Research Focus

    Keywords

  • Schizophrenia
  • Antipsychotics
  • Clozapine
  • Aetiology
  • Clinical Trials
  • Clinical Conditions

  • Schizophrenia
  • Equipment & Techniques

  • Neuropsychological testing
  • Randomised control trials
  • Statistical analysis
  • Computational modelling
  • Science Culture

  • History of Science
  • Philosophy of Science
  • Back

    Emilio Fernandez-Egea MBBS MA (Cantab) DStat MD PhD

    University Position
    Associate Professor
    Affiliated Member
    Dr Emilio Fernandez-Egea is pleased to consider applications from prospective PhD students.

    Interests

    My research interests are mostly the biological and clinical aspects of chronic schizophrenia. I’m the Cambridge Psychosis Centre and Clozapine Clinic Lead for the local MH Trust (Cambridgeshire and Peterborough NHS Foundation Trust). We study all aspects of the treatment resistant schizophrenia including psychosis but mostly the non-psychotic symptoms: poor motivation, decreased emotional life, cognition and others. In our studies, we use different methods and techniques, including blood biomarkers, clinical epidemiology, computational neuroscience, as well as clinical trials with new interventions (both pharmacological and non-pharmacological). Our main lines of research are: 1) the link between metabolic abnormalities and schizophrenia, 2) the understanding of negative symptoms and, 3) uncommon antipsychotic-induced side effects (i.e. compulsive behaviour). Additionally, I am deputy editor for the British Journal of Psychiatry and Spanish Journal of Psychiatry and Mental Health.

    Key Publications

    A new era for the negative symptoms of schizophrenia.

    DOI: http://doi.org/10.1192/bjp.2023.69
    Journal: Br J Psychiatry
    E-pub date: 1 Jul 2023
    Authors: E Fernandez-Egea, A Mucci, J Lee, B Kirkpatrick

    One hundred years ago: Nijinsky and the origins of schizophrenia.

    DOI: http://doi.org/10.1093/brain/awy262
    Journal: Brain
    E-pub date: 1 Jan 2019
    Authors: E Fernandez-Egea

    Metabolic profile of antipsychotic-naive individuals with non-affective psychosis.

    DOI: http://doi.org/10.1192/bjp.bp.108.052605
    Journal: Br J Psychiatry
    E-pub date: 1 May 2009
    Authors: E Fernandez-Egea, M Bernardo, T Donner, I Conget, E Parellada, A Justicia, E Esmatjes, C Garcia-Rizo, B Kirkpatrick

    Is schizophrenia a syndrome of accelerated aging?

    DOI: http://doi.org/10.1093/schbul/sbm140
    Journal: Schizophr Bull
    E-pub date: 1 Nov 2008
    Authors: B Kirkpatrick, E Messias, PD Harvey, E Fernandez-Egea, CR Bowie

    Publications

    An expert Delphi consensus for the characteristics of an ideal clozapine-specific side effect scale

    DOI: http://doi.org/10.1016/j.ejpsy.2024.100267
    Journal: European Journal of Psychiatry
    E-pub date: 1 Oct 2024
    Authors: E Fernández-Egea, M Bernardo

    Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition.

    DOI: http://doi.org/10.1016/j.schres.2023.05.010
    Journal: Schizophr Res
    E-pub date: 1 Jun 2024
    Authors: G Schoretsanitis, AE Anıl Yağcıoğlu, C-J Ruan, CB Eap, E Molden, T Baptista, SR Clark, E Fernandez-Egea, SH Kim, H-Y Lane, J Leung, O Maroñas Amigo, M Motuca, I Olmos, S Every-Palmer, RM Procyshyn, C Rohde, S Satish, PFJ Schulte, E Spina, H Takeuchi, H Verdoux, CU Correll, J de Leon

    Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients: A literature review and a case series of 17 patients from 3 studies.

    DOI: http://doi.org/10.1016/j.schres.2023.07.002
    Journal: Schizophr Res
    E-pub date: 1 Jun 2024
    Authors: C-J Ruan, I Olmos, C Ricciardi, G Schoretsanitis, PD Vincent, AE Anıl Yağcıoğlu, CB Eap, T Baptista, SR Clark, E Fernandez-Egea, SH Kim, H-Y Lane, J Leung, O Maroñas Amigo, M Motuca, S Every-Palmer, RM Procyshyn, C Rohde, S Suhas, PFJ Schulte, E Spina, H Takeuchi, H Verdoux, CU Correll, E Molden, C De Las Cuevas, J de Leon

    Influence of time to clozapine prescription on the clinical outcome.

    DOI: http://doi.org/10.1016/j.schres.2023.09.028
    Journal: Schizophr Res
    E-pub date: 1 Jun 2024
    Authors: LI Muñoz-Manchado, JI Perez-Revuelta, A Banerjee, L Galindo-Guarin, M Bernardo, F González-Saiz, JM Villagrán-Moreno, E Fernández-Egea

    Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK.

    DOI: http://doi.org/10.1016/j.schres.2023.11.010
    Journal: Schizophr Res
    E-pub date: 1 Jun 2024
    Authors: C De Las Cuevas, EJ Sanz, JA Gross, CU Correll, H Verdoux, J Lally, R de Filippis, PFJ Schulte, E Molden, M Arrojo-Romero, AD Bostrom, G Schoretsanitis, E Fernandez-Egea, J de Leon

    Eli Robins: The grandfather of DSM-III

    DOI: http://doi.org/10.1016/j.euroneuro.2024.03.001
    Journal: Eur Neuropsychopharmacol
    E-pub date: 1 Jun 2024
    Authors: B Kirkpatrick, E Fernandez-Egea

    The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational study.

    DOI: http://doi.org/10.1192/bjp.2024.30
    Journal: Br J Psychiatry
    E-pub date: 1 May 2024
    Authors: E Fernandez-Egea, S Chen, E Sangüesa, P Gassó, M Biria, J Plaistow, I Jarratt-Barnham, N Segarra, S Mas, M-P Ribate, CB García, NA Fineberg, Y Worbe, RN Cardinal, TW Robbins

    Anthropometry in antipsychotic-naïve first-episode psychosis patients: An exploratory approach to the role of environmental early life events in two independent samples.

    DOI: http://doi.org/10.1016/j.schres.2024.02.020
    Journal: Schizophr Res
    E-pub date: 1 Apr 2024
    Authors: C Garcia-Rizo, B Crespo-Facorro, C Oliveira, M Gómez-Revuelta, B Kirkpatrick, JM-V Son, LC de la Hoz, M Garriga, N Garrido-Torres, M Bernardo, E Fernandez-Egea, J Vázquez-Bourgon

    Impact of Pharmacogenetic Testing on Clozapine Treatment Efficacy in Patients with Treatment-Resistant Schizophrenia

    DOI: http://doi.org/10.3390/biomedicines12030597
    Journal: Biomedicines
    E-pub date: 7 Mar 2024
    Authors: E Sangüesa, E Fernández-Egea, J Concha, CB García, MP Ribate

    The influence of reward sensitivity on weight in treatment-resistant chronic schizophrenia.

    DOI: http://doi.org/10.1016/j.sjpmh.2024.01.005
    Journal: Span J Psychiatry Ment Health
    E-pub date: 7 Feb 2024
    Authors: I Jarratt Barnham, Y Saleh, M Hussain, E Fernandez-Egea

    The longitudinal structure of negative symptoms in treatment resistant schizophrenia.

    DOI: http://doi.org/10.1016/j.comppsych.2023.152440
    Journal: Compr Psychiatry
    E-pub date: 1 Jan 2024
    Authors: N Wolpe, A Vituri, PB Jones, M Shahar, E Fernandez-Egea

    [The structural stability of negative symptoms over time].

    DOI: http://doi.org/10.1192/bjo.2023.600
    Journal: BJPsych Open
    E-pub date: 3 Nov 2023
    Authors: N Wolpe, E Fernandez-Egea

    Negative symptoms and cognitive impairment are associated with distinct motivational deficits in treatment resistant schizophrenia.

    DOI: http://doi.org/10.1038/s41380-023-02232-7
    Journal: Mol Psychiatry
    E-pub date: 1 Nov 2023
    Authors: Y Saleh, I Jarratt-Barnham, P Petitet, E Fernandez-Egea, SG Manohar, M Husain

    Assessment and the concept of negative symptoms.

    DOI: http://doi.org/10.1016/j.sjpmh.2023.09.006
    Journal: Span J Psychiatry Ment Health
    E-pub date: 29 Oct 2023
    Authors: B Kirkpatrick, E Fernandez-Egea

    Relationship between severe mental illness and physical multimorbidity: a meta-analysis and call for action.

    DOI: http://doi.org/10.1136/bmjment-2023-300870
    Journal: BMJ Ment Health
    E-pub date: 1 Oct 2023
    Authors: D Pizzol, M Trott, L Butler, Y Barnett, T Ford, SA Neufeld, A Ragnhildstveit, CN Parris, BR Underwood, GF López Sánchez, M Fossey, C Brayne, E Fernandez-Egea, G Fond, L Boyer, JI Shin, S Pardhan, L Smith

    Eating disorders and physical multimorbidity in the English general population.

    DOI: http://doi.org/10.1007/s40519-023-01600-0
    Journal: Eat Weight Disord
    E-pub date: 7 Sep 2023
    Authors: L Smith, GF López Sánchez, E Fernandez-Egea, T Ford, C Parris, BR Underwood, L Butler, Y Barnett, M Trott, A Koyanagi

    An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels

    DOI: http://doi.org/10.1016/j.psiq.2023.100415
    Journal: Psiquiatria Biologica
    E-pub date: 1 Sep 2023
    Authors: J de Leon, G Schoretsanitis, RL Smith, E Molden, A Solismaa, N Seppälä, M Kopeček, P Švancer, I Olmos, C Ricciardi, C Iglesias-Garcia, A Iglesias-Alonso, E Spina, CJ Ruan, CY Wang, G Wang, YL Tang, SK Lin, HY Lane, YS Kim, SH Kim, AP Rajkumar, DF González-Esquivel, H Jung-Cook, T Baptista, C Rohde, J Nielsen, H Verdoux, C Quiles, EJ Sanz, C De las Cuevas, D Cohen, PFJ Schulte, A Ertuğrul, AE Anıl Yağcıoğlu, N Chopra, B McCollum, C Shelton, RO Cotes, AR Kaithi, JM Kane, S Farooq, CH Ng, J Bilbily, C Hiemke, C López-Jaramillo, I McGrane, F Lana, CB Eap, M Arrojo-Romero, FŞ Rădulescu, E Seifritz, S Every-Palmer, CA Bousman, E Bebawi, R Bhattacharya, DL Kelly, Y Otsuka, J Lazary, R Torres, A Yecora, M Motuca, SKW Chan, M Zolezzi, S Ouanes, D De Berardis, S Grover, RM Procyshyn, RA Adebayo, OO Kirilochev, A Soloviev, KN Fountoulakis, A Wilkowska, WJ Cubała, M Ayub, A Silva, RM Bonelli, JM Villagrán-Moreno, B Crespo-Facorro, H Temmingh, E Decloedt, MR Pedro, H Takeuchi, M Tsukahara, G Gründer, M Sagud, A Celofiga, D Ignjatovic Ristic, BB Ortiz, H Elkis, AJ Pacheco Palha, A Llerena, E Fernandez-Egea, D Siskind, A Weizman, R Masmoudi, S Mohd Saffian, JG Leung, PF Buckley, SR Marder

    Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group.

    DOI: http://doi.org/10.1093/schbul/sbad030
    Journal: Schizophr Bull
    E-pub date: 4 Jul 2023
    Authors: E Wagner, D Siskind, P Falkai, O Howes, C Correll, J Lee, WG Honer, JM Kane, E Fernandez-Egea, TRE Barnes, A Hasan, TRRIP Working Group

    Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study.

    DOI: http://doi.org/10.1192/bjp.2022.191
    Journal: Br J Psychiatry
    E-pub date: 1 Jul 2023
    Authors: N Wolpe, S Chen, B Kirkpatrick, PB Jones, C Jenkins, RN Cardinal, E Fernandez-Egea

    Author’s Reply. RE: Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study.

    DOI: http://doi.org/10.1192/bjp.2023.84
    Journal: Br J Psychiatry
    E-pub date: 1 Jul 2023
    Authors: N Wolpe, S Chen, B Kirkpatrick, PB Jones, C Jenkins, RN Cardinal, E Fernandez-Egea

    Clozapine-related obsessive-compulsive symptoms and their impact on wellbeing: a naturalistic longitudinal study.

    DOI: http://doi.org/10.1017/S003329172100492X
    Journal: Psychol Med
    E-pub date: 1 May 2023
    Authors: K Parkin, S Chen, M Biria, J Plaistow, H Beckwith, I Jarratt-Barnham, N Segarra, Y Worbe, NA Fineberg, RN Cardinal, TW Robbins, E Fernandez-Egea

    Prefrontal Cortex Activation and Stopping Performance Underlie the Beneficial Effects of Atomoxetine on Response Inhibition in Healthy Volunteers and Those With Cocaine Use Disorder.

    DOI: http://doi.org/10.1016/j.bpsc.2021.08.010
    Journal: Biol Psychiatry Cogn Neurosci Neuroimaging
    E-pub date: 1 Nov 2022
    Authors: P Zhukovsky, S Morein-Zamir, H Ziauddeen, E Fernandez-Egea, C Meng, R Regenthal, BJ Sahakian, ET Bullmore, TW Robbins, JW Dalley, KD Ersche

    The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples.

    DOI: http://doi.org/10.1016/j.lanepe.2022.100493
    Journal: Lancet Reg Health Eur
    E-pub date: 1 Nov 2022
    Authors: BI Perry, F Vandenberghe, N Garrido-Torres, EF Osimo, M Piras, J Vazquez-Bourgon, R Upthegrove, C Grosu, VO-G De La Foz, PB Jones, N Laaboub, M Ruiz-Veguilla, J Stochl, C Dubath, M Canal-Rivero, P Mallikarjun, A Delacrétaz, N Ansermot, E Fernandez-Egea, S Crettol, F Gamma, KJ Plessen, P Conus, GM Khandaker, GK Murray, CB Eap, B Crespo-Facorro

    A clozapine’s uncharted voyage: Five years and a pandemic after the end of mandatory haematological notifications to the Spanish medicines agency

    DOI: http://doi.org/10.1016/j.rpsm.2022.04.001
    Journal: Revista de Psiquiatria y Salud Mental
    E-pub date: 1 Oct 2022
    Authors: P Andres-Olivera, C Turrion, E Fernandez-Egea, J Perez

    Alterations in white matter microstructure in alcohol and alcohol-polydrug dependence: Associations with lifetime alcohol and nicotine exposure

    DOI: http://doi.org/10.1111/adb.13207
    Journal: Addiction Biology
    E-pub date: 1 Sep 2022
    Authors: K Agunbiade, L Fonville, J McGonigle, R Elliott, KD Ersche, R Flechais, C Orban, A Murphy, DG Smith, J Suckling, EM Taylor, B Deakin, TW Robbins, DJ Nutt, AR Lingford-Hughes, LM Paterson, A Lingford-Hughes, L Paterson, R Elliott, A Murphy, E Taylor, K Ersche, D Smith, L Reed, F Passetti, L Faravelli, D Erritzoe, I Mick, N Kalk, A Waldman, L Nestor, S Kuchibatla, V Boyapati, A Metastasio, Y Faluyi, E Fernandez-Egea, S Abbott, B Sahakian, V Voon, I Rabiner

    Multidimensional predictors of negative symptoms in antipsychotic-naive first-episode psychosis.

    DOI: http://doi.org/10.1503/jpn.210138
    Journal: J Psychiatry Neurosci
    E-pub date: 1 Aug 2022
    Authors: A Toll, L Blanco-Hinojo, D Bergé, X Duran, I Canosa, T Legido, F Marmol, V Pérez-Solà, E Fernández-Egea, A Mané

    Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia.

    DOI: http://doi.org/10.1016/j.rpsmen.2020.04.007
    Journal: Rev Psiquiatr Salud Ment (Engl Ed)
    E-pub date: 1 Aug 2022
    Authors: C Martínez-Cao, L García-Álvarez, T Bobes-Bascarán, L de la Fuente-Tomás, E Fernández-Egea, Á Velasco, L González-Blanco, P Zurrón-Madera, E Fonseca-Pedrero, PA Sáiz-Martínez, MP García-Portilla, J Bobes

    Defining negative symptoms remission in schizophrenia using the Brief Negative Symptom Scale.

    DOI: http://doi.org/10.1016/j.rpsmen.2022.01.007
    Journal: Rev Psiquiatr Salud Ment (Engl Ed)
    E-pub date: 1 Aug 2022
    Authors: G Rekhi, MS Ang, YH Chan, E Fernandez-Egea, B Kirkpatrick, J Lee

    The effect of early life events on glucose levels in first-episode psychosis.

    DOI: http://doi.org/10.3389/fendo.2022.983792
    Journal: Front Endocrinol (Lausanne)
    E-pub date: 1 Aug 2022
    Authors: C Garcia-Rizo, B Cabrera, M Bioque, G Mezquida, A Lobo, A Gonzalez-Pinto, CM Diaz-Caneja, I Corripio, E Vieta, I Baeza, MP Garcia-Portilla, M Gutierrez-Fraile, R Rodriguez-Jimenez, M Garriga, E Fernandez-Egea, M Bernardo, PEPs GROUP

    A clozapine’s uncharted voyage: Five years and a pandemic after the end of mandatory haematological notifications to the Spanish medicines agency.

    DOI: http://doi.org/10.1016/j.rpsmen.2022.04.001
    Journal: Rev Psiquiatr Salud Ment (Engl Ed)
    E-pub date: 1 Aug 2022
    Authors: P Andres-Olivera, C Turrion, E Fernandez-Egea, J Perez

    Who is prescribed valproate and how carefully is this treatment reviewed in UK mental health services? Data from a clinical audit.

    DOI: http://doi.org/10.1177/20451253221110016
    Journal: Ther Adv Psychopharmacol
    E-pub date: 1 Aug 2022
    Authors: C Paton, L Citrome, E Fernandez-Egea, O Rendora, TRE Barnes

    Early versus late risk factors for deficit and nondeficit schizophrenia.

    DOI: http://doi.org/10.1016/j.rpsmen.2022.01.006
    Journal: Rev Psiquiatr Salud Ment (Engl Ed)
    E-pub date: 1 Aug 2022
    Authors: S Alabaf, B Kirkpatrick, S Chen, RN Cardinal, E Fernandez-Egea

    Bobby Fischer and the delusions of a king of logic.

    DOI: http://doi.org/10.1093/brain/awac140
    Journal: Brain
    E-pub date: 3 Jun 2022
    Authors: E Fernandez-Egea, TW Robbins

    Is it time to change the term negative symptoms?

    DOI: http://doi.org/10.1016/j.euroneuro.2022.03.004
    Journal: Eur Neuropsychopharmacol
    E-pub date: 1 Jun 2022
    Authors: E Fernandez-Egea, N Wolpe

    Two Factors, Five Factors, or Both? External Validation Studies of Negative Symptom Dimensions in Schizophrenia.

    DOI: http://doi.org/10.1093/schbul/sbab148
    Journal: Schizophr Bull
    E-pub date: 7 May 2022
    Authors: AO Ahmed, B Kirkpatrick, E Granholm, LM Rowland, PB Barker, JM Gold, RW Buchanan, T Outram, M Bernardo, M Paz García-Portilla, A Mane, E Fernandez-Egea, GP Strauss

    An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels.

    DOI: http://doi.org/10.1055/a-1625-6388
    Journal: Pharmacopsychiatry
    E-pub date: 1 Mar 2022
    Authors: J de Leon, G Schoretsanitis, RL Smith, E Molden, A Solismaa, N Seppälä, M Kopeček, P Švancer, I Olmos, C Ricciardi, C Iglesias-Garcia, A Iglesias-Alonso, E Spina, C-J Ruan, C-Y Wang, G Wang, Y-L Tang, S-K Lin, H-Y Lane, YS Kim, SH Kim, AP Rajkumar, DF González-Esquivel, H Jung-Cook, T Baptista, C Rohde, J Nielsen, H Verdoux, C Quiles, EJ Sanz, C De Las Cuevas, D Cohen, PFJ Schulte, A Ertuğrul, AE Anıl Yağcıoğlu, N Chopra, B McCollum, C Shelton, RO Cotes, AR Kaithi, JM Kane, S Farooq, CH Ng, J Bilbily, C Hiemke, C López-Jaramillo, I McGrane, F Lana, CB Eap, M Arrojo-Romero, FŞ Rădulescu, E Seifritz, S Every-Palmer, CA Bousman, E Bebawi, R Bhattacharya, DL Kelly, Y Otsuka, J Lazary, R Torres, A Yecora, M Motuca, SKW Chan, M Zolezzi, S Ouanes, D De Berardis, S Grover, RM Procyshyn, RA Adebayo, OO Kirilochev, A Soloviev, KN Fountoulakis, A Wilkowska, WJ Cubała, M Ayub, A Silva, RM Bonelli, JM Villagrán-Moreno, B Crespo-Facorro, H Temmingh, E Decloedt, MR Pedro, H Takeuchi, M Tsukahara, G Gründer, M Sagud, A Celofiga, D Ignjatovic Ristic, BB Ortiz, H Elkis, AJ Pacheco Palha, A LLerena, E Fernandez-Egea, D Siskind, A Weizman, R Masmoudi, S Mohd Saffian, JG Leung, PF Buckley, SR Marder, L Citrome, O Freudenreich, CU Correll, DJ Müller

    Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels.

    DOI: http://doi.org/10.1055/a-1737-1527
    Journal: Pharmacopsychiatry
    E-pub date: 1 Mar 2022
    Authors: J de Leon, G Schoretsanitis, RL Smith, E Molden, A Solismaa, N Seppälä, M Kopeček, P Švancer, I Olmos, C Ricciardi, C Iglesias-Garcia, A Iglesias-Alonso, E Spina, C-J Ruan, C-Y Wang, G Wang, Y-L Tang, S-K Lin, H-Y Lane, YS Kim, SH Kim, AP Rajkumar, DF González-Esquivel, H Jung-Cook, T Baptista, C Rohde, J Nielsen, H Verdoux, C Quiles, EJ Sanz, C De Las Cuevas, D Cohen, PFJ Schulte, A Ertuğrul, AE Anıl Yağcıoğlu, N Chopra, B McCollum, C Shelton, RO Cotes, AR Kaithi, JM Kane, S Farooq, CH Ng, J Bilbily, C Hiemke, C López-Jaramillo, I McGrane, F Lana, CB Eap, M Arrojo-Romero, FŞ Rădulescu, E Seifritz, S Every-Palmer, CA Bousman, E Bebawi, R Bhattacharya, DL Kelly, Y Otsuka, J Lazary, R Torres, A Yecora, M Motuca, SKW Chan, M Zolezzi, S Ouanes, D De Berardis, S Grover, RM Procyshyn, RA Adebayo, OO Kirilochev, A Soloviev, KN Fountoulakis, A Wilkowska, WJ Cubała, M Ayub, A Silva, RM Bonelli, JM Villagrán-Moreno, B Crespo-Facorro, H Temmingh, E Decloedt, MR Pedro, H Takeuchi, M Tsukahara, G Gründer, M Sagud, A Celofiga, D Ignjatovic Ristic, BB Ortiz, H Elkis, AJ Pacheco Palha, A LLerena, E Fernandez-Egea, D Siskind, A Weizman, R Masmoudi, S Mohd Saffian, JG Leung, PF Buckley, SR Marder, L Citrome, O Freudenreich, CU Correll, DJ Müller

    Risk factors for excess deaths during lockdown among older users of secondary care mental health services without confirmed COVID-19: A retrospective cohort study.

    DOI: http://doi.org/10.1002/gps.5610
    Journal: Int J Geriatr Psychiatry
    E-pub date: 1 Dec 2021
    Authors: S Chen, PB Jones, BR Underwood, E Fernandez-Egea, P Qin, JR Lewis, RN Cardinal

    The sooner the better: clinical and neural correlates of impulsive choice in Tourette disorder.

    DOI: http://doi.org/10.1038/s41398-021-01691-2
    Journal: Transl Psychiatry
    E-pub date: 3 Nov 2021
    Authors: C Atkinson-Clement, A de Liege, Y Klein, B Beranger, R Valabregue, C Delorme, E Roze, E Fernandez-Egea, A Hartmann, TW Robbins, Y Worbe

    Longer-term mortality following SARS-CoV-2 infection in people with severe mental illness: retrospective case-matched study.

    DOI: http://doi.org/10.1192/bjo.2021.1046
    Journal: BJPsych Open
    E-pub date: 1 Nov 2021
    Authors: S Chen, E Fernandez-Egea, PB Jones, JR Lewis, RN Cardinal

    The Effect of Clozapine on Self-reported Duration of Sleep and Its Interaction With 23 Other Medications: A 5-Year Naturalistic Study.

    DOI: http://doi.org/10.1097/JCP.0000000000001432
    Journal: J Clin Psychopharmacol
    E-pub date: 1 Sep 2021
    Authors: E Fernandez-Egea, S Chen, C Jenkins, C Turrion, SP Mitchell, DJF Dodwell, LM Mann, JB Deakin, ZH Syed, S Hafizi, J Zimbron, AS Praseedom, RN Cardinal

    Difficulties in delivery and depressive symptomatology in schizophrenia.

    DOI: http://doi.org/10.1016/j.rpsm.2019.12.002
    Journal: Rev Psiquiatr Salud Ment (Engl Ed)
    E-pub date: 1 Aug 2021
    Authors: G Mezquida, E Fernández-Egea, D Treen, A Mané, D Bergé, G Savulich, L García-Álvarez, MP García-Portilla, J Bobes, M Bernardo, C García-Rizo

    Mechanisms Underlying Motivational Dysfunction in Schizophrenia.

    DOI: http://doi.org/10.3389/fnbeh.2021.709753
    Journal: Front Behav Neurosci
    E-pub date: 1 Aug 2021
    Authors: Y Saleh, I Jarratt-Barnham, E Fernandez-Egea, M Husain

    Waiting for Godot or the use of biomarkers in clinical practice.

    DOI: http://doi.org/10.1016/j.rpsmen.2021.07.003
    Journal: Rev Psiquiatr Salud Ment (Engl Ed)
    E-pub date: 1 Aug 2021
    Authors: E Fernández-Egea

    Women Neuroscientist Disciples of Pío del Río-Hortega: the Cajal School Spreads in Europe and South America.

    DOI: http://doi.org/10.3389/fnana.2021.666938
    Journal: Front Neuroanat
    E-pub date: 1 Aug 2021
    Authors: C Nombela, E Fernández-Egea, E Giné, Y Worbe, J Del Río-Hortega Bereciartu, F de Castro

    Atomoxetine partially restores loss sensitivity in cocaine use disorder

    DOI: http://doi.org/10.1016/j.euroneuro.2021.10.016
    Journal:
    E-pub date: 1 Aug 2021
    Authors: L Cincikas, RN Cardinal, H Ziauddeen, E Fernandez-Egea, R Regenthal, BJ Sahakian, TW Robbins, KD Ersche

    Waiting for Godot or the use of biomarkers in clinical practice.

    DOI: http://doi.org/10.1016/j.rpsm.2021.07.003
    Journal: Rev Psiquiatr Salud Ment
    E-pub date: 1 Jul 2021
    Authors: E Fernández-Egea

    Defining negative symptoms remission in schizophrenia using the Brief Negative Symptom Scale.

    DOI: http://doi.org/10.1016/j.rpsm.2021.05.003
    Journal: Rev Psiquiatr Salud Ment (Engl Ed)
    E-pub date: 29 May 2021
    Authors: G Rekhi, MS Ang, YH Chan, E Fernandez-Egea, B Kirkpatrick, J Lee

    Early versus late risk factors for deficit and nondeficit schizophrenia.

    DOI: http://doi.org/10.1016/j.rpsm.2021.03.002
    Journal: Rev Psiquiatr Salud Ment (Engl Ed)
    E-pub date: 1 Apr 2021
    Authors: S Alabaf, B Kirkpatrick, S Chen, RN Cardinal, E Fernandez-Egea

    Chronic alcohol exposure differentially modulates structural and functional properties of amygdala: A cross-sectional study

    DOI: http://doi.org/10.1111/adb.12980
    Journal: Addiction Biology
    E-pub date: 20 Nov 2020
    Authors: C Orban, J McGonigle, RSA Flechais, LM Paterson, R Elliott, D Erritzoe, KD Ersche, A Murphy, LJ Nestor, F Passetti, LJ Reed, AS Ribeiro, DG Smith, J Suckling, EM Taylor, AD Waldman, VC Wing, JFW Deakin, TW Robbins, DJ Nutt, AR Lingford-Hughes, D Nutt, A Lingford-Hughes, L Paterson, J McGonigle, R Flechais, C Orban, B Deakin, R Elliott, A Murphy, E Taylor, T Robbins, K Ersche, J Suckling, D Smith, L Reed, L Faravelli, D Erritzoe, I Mick, N Kalk, A Waldman, L Nestor, S Kuchibatla, V Boyapati, A Metastasio, Y Faluyi, E Fernandez-Egea, S Abbott, B Sahakian, V Voon, I Rabiner

    Cannabis use influence on peripheral brain-derived neurotrophic factor levels in antipsychotic-naïve first-episode psychosis.

    DOI: http://doi.org/10.1007/s00406-020-01117-y
    Journal: Eur Arch Psychiatry Clin Neurosci
    E-pub date: 1 Oct 2020
    Authors: A Toll, D Bergé, K Burling, L Scoriels, D Treen, C Monserrat, F Marmol, X Duran, PB Jones, V Pérez-Solà, E Fernandez-Egea, A Mané

    Intra-individual variation of clozapine and norclozapine plasma levels in clinical practice.

    DOI: http://doi.org/10.1016/j.rpsm.2019.03.002
    Journal: Rev Psiquiatr Salud Ment (Engl Ed)
    E-pub date: 1 Aug 2020
    Authors: MC Turrion, J Perez, M Bernardo, E Fernandez-Egea

    Sleepwalking Associated With Clozapine Treatment: 2 Cases.

    DOI: http://doi.org/10.1097/JCP.0000000000001208
    Journal: J Clin Psychopharmacol
    E-pub date: 1 Aug 2020
    Authors: NF Daniels, E Fernandez-Egea

    The Medium-Term Impact of COVID-19 Lockdown on Referrals to Secondary Care Mental Health Services: A Controlled Interrupted Time Series Study.

    DOI: http://doi.org/10.3389/fpsyt.2020.585915
    Journal: Front Psychiatry
    E-pub date: 1 Aug 2020
    Authors: S Chen, R She, P Qin, A Kershenbaum, E Fernandez-Egea, JR Nelder, C Ma, J Lewis, C Wang, RN Cardinal

    What happens in naive first-episode of psychosis patients initiating olanzapine treatment? Body mass index gain and improvement in negative symptomatology

    DOI: http://doi.org/10.1016/j.euroneuro.2020.09.414
    Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY
    E-pub date: 1 Aug 2020
    Authors: G Mezquida, M Garriga, S Amoretti, E Fernandez-Egea, A Meseguer, M Vazquez, V Soler-Cata, B Kirkpatrick, M Bernardo, GR Clemente

    Risk Factors for Excess Deaths Among Older Adults Without Confirmed COVID-19 During Lockdown: A Retrospective Cohort Study

    DOI: http://doi.org/10.2139/ssrn.3672334
    Journal:
    E-pub date: 1 Aug 2020
    Authors: S Chen, P Jones, B Underwood, E Fernandez-Egea, P Qin, J Lewis, R Cardinal

    Causes of death in clozapine-treated patients in a catchment area: a 10-year retrospective case-control study.

    DOI: http://doi.org/10.1016/j.euroneuro.2020.05.011
    Journal: Eur Neuropsychopharmacol
    E-pub date: 1 Jul 2020
    Authors: E Rose, S Chen, C Turrion, C Jenkins, RN Cardinal, E Fernandez-Egea

    Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia.

    DOI: http://doi.org/10.1016/j.rpsm.2020.04.008
    Journal: Rev Psiquiatr Salud Ment (Engl Ed)
    E-pub date: 4 Jun 2020
    Authors: C Martínez-Cao, L García-Álvarez, T Bobes-Bascarán, L de la Fuente-Tomás, E Fernández-Egea, Á Velasco, L González-Blanco, P Zurrón-Madera, E Fonseca-Pedrero, PA Sáiz-Martínez, MP García-Portilla, J Bobes

    Structural and functional abnormalities within sensori-motor and limbic networks underpin intermittent explosive symptoms in Tourette disorder.

    DOI: http://doi.org/10.1016/j.jpsychires.2020.02.033
    Journal: J Psychiatr Res
    E-pub date: 1 Jun 2020
    Authors: C Atkinson-Clement, F Sofia, E Fernandez-Egea, A de Liege, B Beranger, Y Klein, E Deniau, E Roze, A Hartmann, Y Worbe

    Longitudinal effects of clozapine concentration and clozapine to N-desmethylclozapine ratio on cognition: A mediation model.

    DOI: http://doi.org/10.1016/j.euroneuro.2020.01.016
    Journal: Eur Neuropsychopharmacol
    E-pub date: 1 Apr 2020
    Authors: F Dal Santo, I Jarratt-Barnham, L González-Blanco, MP García-Portilla, J Bobes, E Fernández-Egea

    Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study.

    DOI: http://doi.org/10.1016/j.schres.2019.12.030
    Journal: Schizophr Res
    E-pub date: 1 Apr 2020
    Authors: C García-Rizo, M Bioque, G Mezquida, S Amoretti, MJ Cuesta, CM Díaz-Caneja, S Mas, A Lobo, A González-Pinto, D Fraguas, I Corripio, E Vieta, I Baeza, D Bergé, E Fernandez-Egea, M Garriga, M Bernardo, PEPs GROUP

    The influence of negative and affective symptoms on anhedonia self-report in schizophrenia.

    DOI: http://doi.org/10.1016/j.comppsych.2020.152165
    Journal: Compr Psychiatry
    E-pub date: 25 Jan 2020
    Authors: I Jarratt-Barnham, Y Saleh, M Husain, B Kirkpatrick, E Fernandez-Egea

    Birth weight, family history of diabetes and diabetes onset in schizophrenia.

    DOI: http://doi.org/10.1136/bmjdrc-2019-001036
    Journal: BMJ Open Diabetes Res Care
    E-pub date: 1 Jan 2020
    Authors: E Fernandez-Egea, R Walker, H Ziauddeen, RN Cardinal, ET Bullmore

    An Early Developmental Marker of Deficit versus Nondeficit Schizophrenia.

    DOI: http://doi.org/10.1093/schbul/sbz024
    Journal: Schizophr Bull
    E-pub date: 24 Oct 2019
    Authors: B Kirkpatrick, Ö Gürbüz Oflezer, M Delice Arslan, G Hack, E Fernandez-Egea

    Naltrexone differentially modulates the neural correlates of motor impulse control in abstinent alcohol-dependent and polysubstance-dependent individuals.

    DOI: http://doi.org/10.1111/ejn.14262
    Journal: Eur J Neurosci
    E-pub date: 31 Aug 2019
    Authors: LJ Nestor, LM Paterson, A Murphy, J McGonigle, C Orban, L Reed, E Taylor, R Flechais, D Smith, ET Bullmore, KD Ersche, J Suckling, R Elliott, B Deakin, I Rabiner, A Lingford Hughes, BJ Sahakian, TW Robbins, DJ Nutt, ICCAM Consortium

    Antipsychotic-induced weight gain and birth weight in psychosis: A fetal programming model.

    DOI: http://doi.org/10.1016/j.jpsychires.2019.05.004
    Journal: J Psychiatr Res
    E-pub date: 31 Aug 2019
    Authors: M Garriga, E Fernandez-Egea, A Mallorqui, L Serrano, C Oliveira, E Parellada, B Kirkpatrick, E Vieta, M Bernardo, C Garcia-Rizo

    A cross sectional study of impact and clinical risk factors of antipsychotic-induced OCD.

    DOI: http://doi.org/10.1016/j.euroneuro.2019.06.006
    Journal: Eur Neuropsychopharmacol
    E-pub date: 31 Aug 2019
    Authors: M Biria, F-X Huang, Y Worbe, NA Fineberg, TW Robbins, E Fernandez-Egea

    Noradrenergic modulation of stopping impulsivity in cocaine use disorder

    DOI: http://doi.org/10.1016/j.euroneuro.2018.11.317
    Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY
    E-pub date: 1 Aug 2019
    Authors: R Rodrigues, S Morein-Zamir, C Meng, H Ziauddeen, E Fernandez-Egea, R Regenthal, BJ Sahakian, ET Bullmore, TW Robbins, KD Ersche

    Influence of secondary sources in the Brief Negative Symptom Scale.

    DOI: http://doi.org/10.1016/j.schres.2018.10.004
    Journal: SCHIZOPHRENIA RESEARCH
    E-pub date: 1 Aug 2019
    Authors: D Treen, G Savulich, G Mezquida, MP García-Portilla, A Toll, C García-Rizo, L García-Álvarez, D Bergé, J Bobes, M Bernardo, E Fernandez-Egea, A Mané

    IDENTIFICATION AND VALIDATION OF THE FIVE-FACTOR MODEL OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA

    DOI: http://doi.org/10.1093/schbul/sbz021.262
    Journal: SCHIZOPHRENIA BULLETIN
    E-pub date: 1 Aug 2019
    Authors: A Ahmed, GP Strauss, E Fernandez-Egea, B Kirkpatrick

    Cross-sectional study of diet patterns in early and chronic schizophrenia.

    DOI: http://doi.org/10.1016/j.schres.2019.03.029
    Journal: Schizophr Res
    E-pub date: 1 Jun 2019
    Authors: L Scoriels, J Zimbron, N Garcia-León, M Coll-Negre, M Giro, J Perez, PB Jones, E Fernandez-Egea

    Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia.

    DOI: http://doi.org/10.1093/schbul/sby050
    Journal: Schizophr Bull
    E-pub date: 7 Mar 2019
    Authors: AO Ahmed, B Kirkpatrick, S Galderisi, A Mucci, A Rossi, A Bertolino, P Rocca, M Maj, S Kaiser, M Bischof, MN Hartmann-Riemer, M Kirschner, K Schneider, MP Garcia-Portilla, A Mane, M Bernardo, E Fernandez-Egea, C Jiefeng, Y Jing, T Shuping, JM Gold, DN Allen, GP Strauss

    Blood cell count in antipsychotic-naive patients with non-affective psychosis.

    DOI: http://doi.org/10.1111/eip.12456
    Journal: Early Interv Psychiatry
    E-pub date: 1 Feb 2019
    Authors: C Garcia-Rizo, M Casanovas, E Fernandez-Egea, C Oliveira, A Meseguer, B Cabrera, G Mezquida, M Bioque, B Kirkpatrick, M Bernardo

    Distinct risk factors for obsessive and compulsive symptoms in chronic schizophrenia.

    DOI: http://doi.org/10.1017/S003329171800017X
    Journal: Psychol Med
    E-pub date: 1 Dec 2018
    Authors: E Fernandez-Egea, Y Worbe, M Bernardo, TW Robbins

    Obstetric Phenotypes in the Heterogeneity of Schizophrenia.

    DOI: http://doi.org/10.1097/NMD.0000000000000897
    Journal: J Nerv Ment Dis
    E-pub date: 1 Nov 2018
    Authors: G Mezquida, E Fernandez-Egea, D Treen, A Mané, D Bergé, G Savulich, L Garcia-Alvarez, P García-Portilla, J Bobes, M Bernardo, C Garcia-Rizo

    A CASE STUDY OF CLOZAPINE AND COGNITION: FRIEND OR FOE?

    DOI: http://doi.org/10.1093/schbul/sby018.856
    Journal: SCHIZOPHRENIA BULLETIN
    E-pub date: 1 Aug 2018
    Authors: G Mezquida, G Savulich, S Atkinson, M Bernardo, E Fernandez-Egea

    DISTINCT RISK FACTORS FOR OBSESSIVE AND COMPULSIVE SYMPTOMS IN SCHIZOPHRENIA

    DOI: http://doi.org/10.1093/schbul/sby018.879
    Journal: SCHIZOPHRENIA BULLETIN
    E-pub date: 1 Aug 2018
    Authors: E Fernandez-Egea, Y Worbe, M Bernardo, TW Robbins

    A Case Study of Clozapine and Cognition: Friend or Foe?

    DOI: http://doi.org/10.1097/JCP.0000000000000847
    Journal: J Clin Psychopharmacol
    E-pub date: 1 Apr 2018
    Authors: G Savulich, G Mezquida, S Atkinson, M Bernardo, E Fernandez-Egea

    Inverse association between negative symptoms and body mass index in chronic schizophrenia.

    DOI: http://doi.org/10.1016/j.schres.2017.04.002
    Journal: Schizophr Res
    E-pub date: 1 Feb 2018
    Authors: G Mezquida, G Savulich, C Garcia-Rizo, MP Garcia-Portilla, A Toll, L Garcia-Alvarez, J Bobes, A Mané, M Bernardo, E Fernandez-Egea

    The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study.

    DOI: http://doi.org/10.1016/j.schres.2017.01.047
    Journal: Schizophr Res
    E-pub date: 1 Nov 2017
    Authors: G Mezquida, B Cabrera, M Bioque, S Amoretti, A Lobo, A González-Pinto, A Espliego, I Corripio, E Vieta, J Castro-Fornieles, D Bergé, MJ Escartí, Á Ibañez, R Penadés, AM Sánchez-Torres, M Bernardo, PEPs Group

    SLC6A2 genotype variation and the modulatory effects of atomoxetine on inhibitory control in individuals with and without cocaine use disorder

    DOI: http://doi.org/10.1016/S0924-977X(17)31865-5
    Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY
    E-pub date: 1 Aug 2017
    Authors: AN Le, H Ziauddeen, E Fernandez-Egea, R Regenthal, BJ Sahakian, ET Bullmore, TW Robbins, KD Ersche

    Reality monitoring impairment in schizophrenia reflects specific prefrontal cortex dysfunction.

    DOI: http://doi.org/10.1016/j.nicl.2017.01.028
    Journal: Neuroimage Clin
    E-pub date: 1 Aug 2017
    Authors: JR Garrison, E Fernandez-Egea, R Zaman, M Agius, JS Simons

    Obstetric complications and cognitive function in schizophrenia

    DOI: http://doi.org/10.1016/S0924-977X(17)31622-X
    Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY
    E-pub date: 1 Aug 2017
    Authors: G Mezquida, E Fernandez-Egea, D Treen, A Mane, D Berge, L Garcia-Alvarez, P Garcia-Portilla, J Bobes, M Bernardo, C Garcia-Rizo

    Neural basis of impaired safety signaling in Obsessive Compulsive Disorder.

    DOI: http://doi.org/10.1073/pnas.1609194114
    Journal: Proc Natl Acad Sci U S A
    E-pub date: 21 Mar 2017
    Authors: AM Apergis-Schoute, CM Gillan, NA Fineberg, E Fernandez-Egea, BJ Sahakian, TW Robbins

    Metabolic syndrome or glucose challenge in first episode of psychosis?

    DOI: http://doi.org/10.1016/j.eurpsy.2016.10.001
    Journal: Eur Psychiatry
    E-pub date: 1 Mar 2017
    Authors: C Garcia-Rizo, E Fernandez-Egea, C Oliveira, A Meseguer, B Cabrera, G Mezquida, M Bioque, R Penades, E Parellada, M Bernardo, B Kirkpatrick

    Visual Population Receptive Fields in People with Schizophrenia Have Reduced Inhibitory Surrounds.

    DOI: http://doi.org/10.1523/JNEUROSCI.3620-15.2016
    Journal: J Neurosci
    E-pub date: 8 Feb 2017
    Authors: EJ Anderson, MS Tibber, DS Schwarzkopf, SS Shergill, E Fernandez-Egea, G Rees, SC Dakin

    Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naïve patients with nonaffective psychosis.

    DOI: http://doi.org/10.1016/j.schres.2016.09.026
    Journal: Schizophr Res
    E-pub date: 1 Jan 2017
    Authors: AM Greenhalgh, L Gonzalez-Blanco, C Garcia-Rizo, E Fernandez-Egea, B Miller, MB Arroyo, B Kirkpatrick

    Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders.

    DOI: http://doi.org/10.1016/j.eurpsy.2016.04.011
    Journal: Eur Psychiatry
    E-pub date: 1 Oct 2016
    Authors: G Mezquida, R Penadés, B Cabrera, G Savulich, A Lobo, A González-Pinto, MJ Penzol, I Corripio, E Fernandez-Egea, P Gassó, MJ Cuesta, M Bernardo, PEPs group

    A systematic review and meta-analysis of randomised controlled trials of treatments for clozapine-induced obesity and metabolic syndrome.

    DOI: http://doi.org/10.1016/j.euroneuro.2016.07.010
    Journal: Eur Neuropsychopharmacol
    E-pub date: 1 Sep 2016
    Authors: J Zimbron, GM Khandaker, C Toschi, PB Jones, E Fernandez-Egea

    Peripheral Immune Cell Populations Associated with Cognitive Deficits and Negative Symptoms of Treatment-Resistant Schizophrenia.

    DOI: http://doi.org/10.1371/journal.pone.0155631
    Journal: PLoS One
    E-pub date: 1 Aug 2016
    Authors: E Fernandez-Egea, PE Vértes, SM Flint, L Turner, S Mustafa, A Hatton, KGC Smith, PA Lyons, ET Bullmore

    An observational study of clozapine-induced sedation and its pharmacological management

    DOI: http://doi.org/10.1016/j.eurpsy.2016.01.091
    Journal: EUROPEAN PSYCHIATRY
    E-pub date: 1 Aug 2016
    Authors: S Ramos Perdigues, A Mane Santacana, RB Sauras Quetcuti, E Fernandez-Egea

    Well-being in clozapine-treated schizophrenia patients: The significance of positive symptoms.

    DOI: http://doi.org/10.1016/j.comppsych.2016.04.009
    Journal: Compr Psychiatry
    E-pub date: 1 Jul 2016
    Authors: JEH Brown, G Mezquida, E Fernandez-Egea

    Prolactin concentrations in antipsychotic-naïve patients with schizophrenia and related disorders: A meta-analysis.

    DOI: http://doi.org/10.1016/j.schres.2016.03.018
    Journal: Schizophr Res
    E-pub date: 1 Jul 2016
    Authors: L González-Blanco, AMD Greenhalgh, C Garcia-Rizo, E Fernandez-Egea, BJ Miller, B Kirkpatrick

    Association of birth weight and the development of antipsychotic induced adiposity in individuals with treatment resistant schizophrenia.

    DOI: http://doi.org/10.1016/j.euroneuro.2016.03.008
    Journal: Eur Neuropsychopharmacol
    E-pub date: 1 Jun 2016
    Authors: H Ziauddeen, C Garcia-Rizo, M Bernardo, B Kirkpatrick, SE Ozanne, PB Jones, E Fernandez-Egea

    Valence-dependent influence of serotonin depletion on model-based choice strategy.

    DOI: http://doi.org/10.1038/mp.2015.46
    Journal: Mol Psychiatry
    E-pub date: 1 May 2016
    Authors: Y Worbe, S Palminteri, G Savulich, ND Daw, E Fernandez-Egea, TW Robbins, V Voon

    Abnormal glycemic homeostasis at the onset of serious mental illnesses: A common pathway.

    DOI: http://doi.org/10.1016/j.psyneuen.2016.02.001
    Journal: Psychoneuroendocrinology
    E-pub date: 1 May 2016
    Authors: C Garcia-Rizo, B Kirkpatrick, E Fernandez-Egea, C Oliveira, M Bernardo

    Impulsivity in abstinent alcohol and polydrug dependence: a multidimensional approach.

    DOI: http://doi.org/10.1007/s00213-016-4245-6
    Journal: Psychopharmacology (Berl)
    E-pub date: 1 Apr 2016
    Authors: EM Taylor, A Murphy, V Boyapati, KD Ersche, R Flechais, S Kuchibatla, J McGonigle, A Metastasio, L Nestor, C Orban, F Passetti, L Paterson, D Smith, J Suckling, R Tait, AR Lingford-Hughes, TW Robbins, DJ Nutt, JFW Deakin, R Elliott, ICCAM Platform

    An observational study of clozapine induced sedation and its pharmacological management.

    DOI: http://doi.org/10.1016/j.euroneuro.2015.11.006
    Journal: Eur Neuropsychopharmacol
    E-pub date: 1 Jan 2016
    Authors: S Ramos Perdigués, R Sauras Quecuti, A Mané, L Mann, C Mundell, E Fernandez-Egea

    The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people.

    DOI: http://doi.org/10.1098/rstb.2014.0214
    Journal: Philos Trans R Soc Lond B Biol Sci
    E-pub date: 19 Sep 2015
    Authors: BJ Sahakian, AB Bruhl, J Cook, C Killikelly, G Savulich, T Piercy, S Hafizi, J Perez, E Fernandez-Egea, J Suckling, PB Jones

    The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description.

    DOI: http://doi.org/10.1177/0269881115596155
    Journal: J Psychopharmacol
    E-pub date: 1 Sep 2015
    Authors: LM Paterson, RSA Flechais, A Murphy, LJ Reed, S Abbott, V Boyapati, R Elliott, D Erritzoe, KD Ersche, Y Faluyi, L Faravelli, E Fernandez-Egea, NJ Kalk, SS Kuchibatla, J McGonigle, A Metastasio, I Mick, L Nestor, C Orban, F Passetti, EA Rabiner, DG Smith, J Suckling, R Tait, EM Taylor, AD Waldman, TW Robbins, JFW Deakin, DJ Nutt, AR Lingford-Hughes, ICCAM Platform

    The negative syndrome of schizophrenia: three -underlying components are better than two.

    DOI: http://doi.org/10.1016/j.schres.2015.05.003
    Journal: Schizophr Res
    E-pub date: 31 Aug 2015
    Authors: MP Garcia-Portilla, L Garcia-Alvarez, A Mané, C Garcia-Rizo, G Sugranyes, D Bergé, M Bernardo, E Fernández-Egea, J Bobes

    Tryptophan Depletion Promotes Habitual over Goal-Directed Control of Appetitive Responding in Humans.

    DOI: http://doi.org/10.1093/ijnp/pyv013
    Journal: Int J Neuropsychopharmacol
    E-pub date: 5 Feb 2015
    Authors: Y Worbe, G Savulich, S de Wit, E Fernandez-Egea, TW Robbins

    The thrifty psychiatric phenotype.

    DOI: http://doi.org/10.1111/acps.12309
    Journal: Acta Psychiatrica Scandinavica
    E-pub date: 1 Jan 2015
    Authors: C Garcia-Rizo, E Fernandez-Egea, M Bernardo, B Kirkpatrick

    Spanish adaptation and validation of the Brief Negative Symptoms Scale.

    DOI: http://doi.org/10.1016/j.comppsych.2014.05.024
    Journal: Comprehensive Psychiatry
    E-pub date: 1 Oct 2014
    Authors: A Mané, C García-Rizo, MP Garcia-Portilla, D Bergé, G Sugranyes, L Garcia-Alvarez, M Bernardo, J Bobes, E Fernandez-Egea

    Brain metabolism during hallucination-like auditory stimulation in schizophrenia.

    DOI: http://doi.org/10.1371/journal.pone.0084987
    Journal: PLoS One
    E-pub date: 1 Aug 2014
    Authors: G Horga, E Fernández-Egea, A Mané, M Font, KC Schatz, C Falcon, F Lomeña, M Bernardo, E Parellada

    SPANISH ADAPTATION AND VALIDATION OF THE BRIEF NEGATIVE SYNDROME SCALE

    DOI: http://doi.org/10.1016/S0920-9964(14)70447-5
    Journal: SCHIZOPHRENIA RESEARCH
    E-pub date: 1 Aug 2014
    Authors: AM Santacana, C Garcia-Rizo, D Berge, MP Garcia-Portilla, L Garcia, G Sugranyes, M Bernardo, J Bobes, E Fernandez-Egea

    Serotonin depletion induces ‘waiting impulsivity’ on the human four-choice serial reaction time task: cross-species translational significance.

    DOI: http://doi.org/10.1038/npp.2013.351
    Journal: Neuropsychopharmacology
    E-pub date: 1 May 2014
    Authors: Y Worbe, G Savulich, V Voon, E Fernandez-Egea, TW Robbins

    Distribution of tract deficits in schizophrenia.

    DOI: http://doi.org/10.1186/1471-244X-14-99
    Journal: BMC Psychiatry
    E-pub date: 2 Apr 2014
    Authors: I Ellison-Wright, PJ Nathan, ET Bullmore, R Zaman, RB Dudas, M Agius, E Fernandez-Egea, U Müller, CM Dodds, NJ Forde, C Scanlon, A Leemans, C McDonald, DM Cannon

    Schizophrenia: a systemic disorder.

    DOI: http://doi.org/10.3371/CSRP.KIMI.031513
    Journal: Clinical Schizophrenia and Related Psychoses
    E-pub date: 1 Jan 2014
    Authors: B Kirkpatrick, B Miller, C García-Rizo, E Fernandez-Egea

    “Is bipolar disorder an endocrine condition?” Glucose abnormalities in bipolar disorder.

    DOI: http://doi.org/10.1111/acps.12194
    Journal: Acta Psychiatrica Scandinavica
    E-pub date: 1 Jan 2014
    Authors: C Garcia-Rizo, B Kirkpatrick, E Fernandez-Egea, C Oliveira, A Meseguer, I Grande, J Undurraga, E Vieta, M Bernardo

    Cannabis use is associated with increased CCL11 plasma levels in young healthy volunteers.

    DOI: http://doi.org/10.1016/j.pnpbp.2013.06.011
    Journal: Prog Neuropsychopharmacol Biol Psychiatry
    E-pub date: 1 Oct 2013
    Authors: E Fernandez-Egea, L Scoriels, S Theegala, M Giro, SE Ozanne, K Burling, PB Jones

    Oscillatory underpinnings of mismatch negativity and their relationship with cognitive function in patients with schizophrenia.

    DOI: http://doi.org/10.1371/journal.pone.0083255
    Journal: PLoS One
    E-pub date: 1 Aug 2013
    Authors: M Kaser, F Soltesz, P Lawrence, S Miller, C Dodds, R Croft, RB Dudas, R Zaman, E Fernandez-Egea, U Müller, A Dean, ET Bullmore, PJ Nathan

    Corrigendum to “Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features” [Psychiatry Res. 198 (2012) 212-215]

    DOI: http://doi.org/10.1016/j.psychres.2013.08.041
    Journal: PSYCHIATRY RESEARCH
    E-pub date: 1 Aug 2013
    Authors: C Garcia-Rizo, E Fernandez-Egea, C Oliveira, A Justicia, M Bernardo, B Kirkpatrick

    Cannabis use is associated with biological markers of ageing in healthy volunteers

    DOI: http://doi.org/10.1016/S0924-977X(13)70899-X
    Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY
    E-pub date: 1 Aug 2013
    Authors: L Scoriels, S Theegala, M Giro, SE Ozanne, K Burling, PB Jones, E Fernandez-Egea

    Glucose abnormalities in newly diagnosed, medication-naive patients with bipolar disorder, mania, and psychosis

    DOI: http://doi.org/10.1016/S0924-977X(13)70108-1
    Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY
    E-pub date: 1 Aug 2013
    Authors: C Garcia-Rizo, B Kirkpatrick, E Fernandez-Egea, C Oliveira, I Grande, J Undurraga, E Vieta, M Bernardo

    Screening for substance use disorders in first-episode psychosis: implications for readmission.

    DOI: http://doi.org/10.1016/j.schres.2013.02.031
    Journal: Schizophrenia Research
    E-pub date: 1 May 2013
    Authors: A Batalla, C Garcia-Rizo, P Castellví, E Fernandez-Egea, M Yücel, E Parellada, B Kirkpatrick, R Martin-Santos, M Bernardo

    Diabetes or prediabetes in newly diagnosed patients with nonaffective psychosis? A historical and contemporary view.

    DOI: http://doi.org/10.1093/schbul/sbs134
    Journal: Schizophr Bull
    E-pub date: 1 Mar 2013
    Authors: E Fernandez-Egea, C Garcia-Rizo, J Zimbron, B Kirkpatrick

    Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naïve patients with depression.

    DOI: http://doi.org/10.1016/j.bbi.2012.11.009
    Journal: Brain, Behavior, and Immunity
    E-pub date: 1 Feb 2013
    Authors: C Garcia-Rizo, E Fernandez-Egea, BJ Miller, C Oliveira, A Justicia, JK Griffith, CM Heaphy, M Bernardo, B Kirkpatrick

    Should obesity be a limiting factor for clozapine treatment?

    DOI: http://doi.org/10.1016/j.rpsm.2012.05.005
    Journal: Revista de Psiquiatria y Salud Mental
    E-pub date: 1 Jan 2013
    Authors: A Pons i Villanueva, A Romero, J Goti, E Fernandez-Egea, J Undurraga, X Carne, M Bernardo

    Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features.

    DOI: http://doi.org/10.1016/j.psychres.2011.08.014
    Journal: Psychiatry Research
    E-pub date: 30 Jul 2012
    Authors: C Garcia-Rizo, E Fernandez-Egea, C Oliveira, A Justicia, M Bernardo, B Kirkpatrick

    Left amygdalar activation in deficit syndrome compared with non-deficit subjects with schizophrenia during the control task in a facial emotion recognition paradigm.

    DOI: http://doi.org/10.1016/j.pscychresns.2011.09.016
    Journal: Psychiatry Research - Neuroimaging
    E-pub date: 30 Jul 2012
    Authors: E Fernandez-Egea, E Parelada, G Sugranyes, G Horga, F Lomeña, C Falcon, J Pavia, M Bermardo

    Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot study.

    DOI: http://doi.org/10.1097/YCT.0b013e31823c98c0
    Journal: J ECT
    E-pub date: 1 Jun 2012
    Authors: LP Pintor, F Valldeoriola, E Fernández-Egea, R Sánchez, L Rami, E Tolosa, A Muñiz, MJ Martí, M Bernardo

    Is abnormal glucose tolerance in antipsychotic-naive patients with nonaffective psychosis confounded by poor health habits?

    DOI: http://doi.org/10.1093/schbul/sbq058
    Journal: Schizophr Bull
    E-pub date: 1 Mar 2012
    Authors: B Kirkpatrick, BJ Miller, C Garcia-Rizo, E Fernandez-Egea, M Bernardo

    Prolactin concentrations in newly diagnosed, antipsychotic-naïve patients with nonaffective psychosis.

    DOI: http://doi.org/10.1016/j.schres.2011.07.025
    Journal: Schizophr Res
    E-pub date: 1 Jan 2012
    Authors: C Garcia-Rizo, E Fernandez-Egea, C Oliveira, A Justicia, E Parellada, M Bernardo, B Kirkpatrick

    A 4-year dopamine transporter (DAT) imaging study in neuroleptic-naive first episode schizophrenia patients.

    DOI: http://doi.org/10.1016/j.pscychresns.2011.03.004
    Journal: Psychiatry Res
    E-pub date: 31 Oct 2011
    Authors: A Mané, J Gallego, F Lomeña, JJ Mateos, E Fernandez-Egea, G Horga, A Cot, J Pavia, M Bernardo, E Parellada

    Testosterone in newly diagnosed, antipsychotic-naive men with nonaffective psychosis: a test of the accelerated aging hypothesis.

    DOI: http://doi.org/10.1097/PSY.0b013e318230343f
    Journal: Psychosom Med
    E-pub date: 1 Oct 2011
    Authors: E Fernandez-Egea, C García-Rizo, B Miller, E Parellada, A Justicia, M Bernardo, B Kirkpatrick

    Differential brain glucose metabolic patterns in antipsychotic-naïve first-episode schizophrenia with and without auditory verbal hallucinations.

    DOI: http://doi.org/10.1503/jpn.100085
    Journal: J Psychiatry Neurosci
    E-pub date: 1 Sep 2011
    Authors: G Horga, E Parellada, F Lomeña, E Fernández-Egea, A Mané, M Font, C Falcón, AB Konova, J Pavia, D Ros, M Bernardo

    Metabolic effects of olanzapine in patients with newly diagnosed psychosis.

    DOI: http://doi.org/10.1097/JCP.0b013e31820fcea3
    Journal: J Clin Psychopharmacol
    E-pub date: 1 Apr 2011
    Authors: E Fernandez-Egea, B Miller, C Garcia-Rizo, M Bernardo, B Kirkpatrick

    Spanish validation of the Brief Assessment in Cognition in Schizophrenia (BACS) in patients with schizophrenia and healthy controls.

    DOI: http://doi.org/10.1016/j.eurpsy.2009.11.001
    Journal: Eur Psychiatry
    E-pub date: 1 Mar 2011
    Authors: N Segarra, M Bernardo, F Gutierrez, A Justicia, E Fernadez-Egea, M Allas, G Safont, F Contreras, J Gascon, PA Soler-Insa, JM Menchon, C Junque, RSE Keefe

    Cholesterol and triglycerides in antipsychotic-naive patients with nonaffective psychosis.

    DOI: http://doi.org/10.1016/j.psychres.2010.06.001
    Journal: Psychiatry Res
    E-pub date: 15 Aug 2010
    Authors: B Kirkpatrick, C Garcia-Rizo, K Tang, E Fernandez-Egea, M Bernardo

    TESTOSTERONE IN NEWLY DIAGNOSED, ANTIPSYCHOTIC-NAIVE MEN WITH NONAFFECTIVE PSYCHOSIS: A TEST OF THE ACCELERATED AGING HYPOTHESIS

    DOI: http://doi.org/10.1016/j.schres.2010.02.491
    Journal: SCHIZOPHRENIA RESEARCH
    E-pub date: 1 Apr 2010
    Authors: E Fernandez-Egea, C Garcia-Rizo, B Miller, A Justicia, M Bernardo, B Kirkpatrick

    18FDG PET study of amygdalar activity during facial emotion recognition in schizophrenia.

    DOI: http://doi.org/10.1007/s00406-009-0020-6
    Journal: Eur Arch Psychiatry Clin Neurosci
    E-pub date: 1 Feb 2010
    Authors: E Fernandez-Egea, E Parellada, F Lomeña, C Falcon, J Pavia, A Mane, G Horga, M Bernardo

    Stem cell signaling in newly diagnosed, antipsychotic-naive subjects with nonaffective psychosis.

    DOI: http://doi.org/10.1038/mp.2009.45
    Journal: Mol Psychiatry
    E-pub date: 1 Nov 2009
    Authors: E Fernandez-Egea, A Bruna, C Garcia-Rizo, M Bernardo, B Kirkpatrick

    Progressive gray matter changes in first episode schizophrenia: a 4-year longitudinal magnetic resonance study using VBM.

    DOI: http://doi.org/10.1016/j.schres.2009.07.014
    Journal: Schizophr Res
    E-pub date: 1 Oct 2009
    Authors: A Mané, C Falcon, JJ Mateos, E Fernandez-Egea, G Horga, F Lomeña, N Bargalló, A Prats-Galino, M Bernardo, E Parellada

    Adaptation and validation of the Spanish version of the Strauss and Carpenter Prognostic Scale for Schizophrenia.

    DOI: http://doi.org/10.1016/S1888-9891(09)73233-1
    Journal: Revista de Psiquiatria y Salud Mental
    E-pub date: 1 Oct 2009
    Authors: M Ahuir, M Bernardo, E de la Serna, S Ochoa, J Carlson, G Escartín, A Gutiérrez-Zotes, J Valero, M Salamero, S Cañizares, E Fernández-Egea, J Cañete, P Gallo

    Psychosis and catatonia as a first presentation of antiphospholipid syndrome.

    DOI: http://doi.org/10.1192/bjp.195.3.272
    Journal: Br J Psychiatry
    E-pub date: 1 Sep 2009
    Authors: RN Cardinal, DN Shah, CJ Edwards, GRV Hughes, E Fernández-Egea

    Cannabis use and age of diagnosis of schizophrenia.

    DOI: http://doi.org/10.1016/j.eurpsy.2009.01.002
    Journal: Eur Psychiatry
    E-pub date: 1 Jun 2009
    Authors: G Sugranyes, I Flamarique, E Parellada, I Baeza, J Goti, E Fernandez-Egea, M Bernardo

    A continuous emotional task activates the left amygdala in healthy volunteers: (18)FDG PET study.

    DOI: http://doi.org/10.1016/j.pscychresns.2008.01.003
    Journal: Psychiatry Res
    E-pub date: 31 Mar 2009
    Authors: E Fernandez-Egea, E Parellada, F Lomeña, C Falcon, J Pavia, A Mane, G Sugranyes, M Valdes, M Bernardo

    Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis.

    DOI: http://doi.org/10.1093/schbul/sbn169
    Journal: Schizophr Bull
    E-pub date: 1 Mar 2009
    Authors: E Fernandez-Egea, M Bernardo, CM Heaphy, JK Griffith, E Parellada, E Esmatjes, I Conget, L Nguyen, V George, H Stöppler, B Kirkpatrick

    Differences in glucose tolerance between deficit and nondeficit schizophrenia.

    DOI: http://doi.org/10.1016/j.schres.2008.09.023
    Journal: Schizophr Res
    E-pub date: 1 Feb 2009
    Authors: B Kirkpatrick, E Fernandez-Egea, C Garcia-Rizo, M Bernardo

    Fluordeoxyglucose-PET study in first-episode schizophrenic patients during the hallucinatory state, after remission and during linguistic-auditory activation.

    DOI: http://doi.org/10.1097/MNM.0b013e328302cd10
    Journal: Nucl Med Commun
    E-pub date: 1 Oct 2008
    Authors: E Parellada, F Lomena, M Font, D Pareto, F Gutierrez, M Simo, E Fernández-Egea, J Pavia, D Ros, M Bernardo

    Glucose abnormalities in the siblings of people with schizophrenia.

    DOI: http://doi.org/10.1016/j.schres.2008.04.017
    Journal: Schizophr Res
    E-pub date: 31 Aug 2008
    Authors: E Fernandez-Egea, M Bernardo, E Parellada, A Justicia, C Garcia-Rizo, E Esmatjes, I Conget, B Kirkpatrick

    Parental history of type 2 diabetes in patients with nonaffective psychosis.

    DOI: http://doi.org/10.1016/j.schres.2007.10.002
    Journal: Schizophr Res
    E-pub date: 1 Jan 2008
    Authors: E Fernandez-Egea, B Miller, M Bernardo, T Donner, B Kirkpatrick

    [Adaptation and validation into Spanish of Schedule for the Deficit Syndrome].

    DOI: http://doi.org/10.1157/13107363
    Journal: Medicina Clinica
    E-pub date: 16 Jun 2007
    Authors: M Bernardo, E Fernández-Egea, A Torras, F Gutiérrez, M Ahuir, C Arango

    [Value of screening test for syphilis in acute psychiatric inpatients].

    DOI: http://doi.org/10.1157/13106941
    Journal: Medicina Clinica
    E-pub date: 9 Jun 2007
    Authors: E Gómez-Gil, E Fernández-Egea, A Trilla, M Almela

    Psychiatric disorders in temporal lobe epilepsy patients over the first year after surgical treatment.

    DOI: http://doi.org/10.1016/j.seizure.2006.12.004
    Journal: Seizure
    E-pub date: 1 Apr 2007
    Authors: L Pintor, E Bailles, E Fernández-Egea, V Sánchez-Gistau, X Torres, M Carreño, J Rumia, S Matrai, T Boget, T Raspall, A Donaire, N Bargalló, X Setoain

    Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait.

    DOI: http://doi.org/10.1007/s00213-006-0570-5
    Journal: Psychopharmacology (Berl)
    E-pub date: 1 Apr 2007
    Authors: JJ Mateos, F Lomeña, E Parellada, F Mireia, E Fernandez-Egea, J Pavia, A Prats, F Pons, M Bernardo

    Palate and dentition in schizophrenia.

    DOI: http://doi.org/10.1016/j.schres.2006.12.022
    Journal: Schizophr Res
    E-pub date: 1 Mar 2007
    Authors: B Kirkpatrick, GD Hack, E Higginbottom, D Hoffacker, E Fernandez-Egea

    Fertility of first-degree relatives of patients with schizophrenia: a three generation perspective.

    DOI: http://doi.org/10.1016/j.schres.2006.12.002
    Journal: Schizophr Res
    E-pub date: 1 Mar 2007
    Authors: AC Svensson, P Lichtenstein, S Sandin, CM Hultman

    The role of the amygdala in facial emotion recognition in schizophrenia

    DOI: http://doi.org/10.1016/s1134-5934(07)73257-8
    Journal: Psiquiatria Biologica
    E-pub date: 1 Jan 2007
    Authors: E Fernández-Egea, EP Rodon, FL Caballero, AM Santacana, MB Arroyo

    Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism.

    DOI: http://doi.org/10.1007/s00213-005-2250-2
    Journal: Psychopharmacology (Berl)
    E-pub date: 1 Sep 2005
    Authors: JJ Mateos, F Lomeña, E Parellada, M Font, E Fernandez, J Pavia, A Prats, F Pons, M Bernardo

    Psychiatric disorders, trauma, and MMPI profile in a Spanish sample of nonepileptic seizure patients.

    DOI: http://doi.org/10.1016/j.genhosppsych.2004.04.003
    Journal: Gen Hosp Psychiatry
    E-pub date: 1 Aug 2004
    Authors: E Baillés, L Pintor, E Fernandez-Egea, X Torres, S Matrai, J De Pablo, S Arroyo

    Lack of sex differences in striatal dopamine D2 receptor binding in drug-naive schizophrenic patients: an IBZM-SPECT study.

    DOI: http://doi.org/10.1016/j.pscychresns.2003.05.001
    Journal: Psychiatry Res
    E-pub date: 15 Jan 2004
    Authors: E Parellada, F Lomeña, AM Catafau, M Bernardo, M Font, E Fernández-Egea, J Pavía, F Gutierrez

    [Relationship between patient’s subjective stress perception and the course of inflammatory bowel disease].

    DOI: http://doi.org/10.1016/s0210-5705(03)70382-3
    Journal: Gastroenterol Hepatol
    E-pub date: 1 Aug 2003
    Authors: E Gómez-Gil, A Vidal, J Panés, J Jaén, JM Peri, E Fernández-Egea, JM Piqué

    Relationship between patient’s subjective stress perception and the course of inflammatory bowel disease

    DOI: http://doi.org/10.1157/13050353
    Journal: Gastroenterologia y Hepatologia
    E-pub date: 1 Jan 2003
    Authors: E Gómez-Gil, A Vidal, J Panés, J Jaén, JM Peri, E Fernández-Egea, JM Piqué

    [Serological testing and prevalence of human immunodeficiency, hepatitis B and C viruses infections amongst acute psychiatric inpatients].

    DOI: http://doi.org/10.1016/s0025-7753(02)73543-4
    Journal: Medicina Clinica
    E-pub date: 23 Nov 2002
    Authors: E Fernández-Egea, E Gómez Gil, B Corbella Santomà, M Salamero Baró, J Blanch Andreu, M Valdés Miyar

    Lack of clinical relevance of routine chest radiography in acute psychiatric admissions.

    DOI: http://doi.org/10.1016/s0163-8343(01)00179-7
    Journal: Gen Hosp Psychiatry
    E-pub date: 1 Aug 2002
    Authors: E Gómez-Gil, A Trilla, B Corbella, E Fernández-Egea, P Luburich, J de Pablo, J Ferrer Raldúa, M Valdés